1402008-44-9

Basic information

• Product Name: trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexane lithium carboxylate
• Synonyms: trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexane lithium carboxylate
• CAS NO: 1402008-44-9
• Molecular Weight: 383.377
• Mol File: 1402008-44-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexane lithium carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexane lithium carboxylate(1402008-44-9)
• EPA Substance Registry System: trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexane lithium carboxylate(1402008-44-9)

Safety Data

• Hazardous Substances Data: 1402008-44-9(Hazardous Substances Data)

Upstream product

• 50738-63-1 trans-4-aminomethyl-cyclohexanecarboxylic acid methyl ester 
• 1402008-43-8 trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-7-methyl-8-oxo-7,8-dihydro-purin-9-ylmethyl}-cyclohexanecarboxylic acid methyl ester 
• 1402008-42-7 trans-4-{2-[(2-methoxy-ethyl)-methyl-amino]-8-oxo-7,8-dihydro-purin-9 ylmethyl}-cyclohexanecarboxylic acid methyl ester 

Relevant articles and documents

WNT PATHWAY ANTAGONISTS

The present invention relates to novel compounds of formula (I): as herein described and pharmaceutical compositions thereof. The compounds of formula (I) have inhibitory effect on the Wnt pathway and are therefore useful in the preparation of a medicament, in particular for the treatment of cancer.